Label-free integrative pharmacology on-target of drugs at the β 2-adrenergic receptor

Scientific Reports

Volumn 1, Issue , 2011, Pages

  Ferrie, Ann M ^a   Sun, Haiyan ^a   Fang, Ye ^a  

^a Corning Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG;

ARTICLE; BIOASSAY; CELL SEPARATION; DRUG EFFECT; DRUG SCREENING; EQUIPMENT; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FLOW CYTOMETRY; GENETIC PROCEDURES; MICROFLUIDIC ANALYSIS; PROTEIN ANALYSIS; STAINING; SYSTEM ANALYSIS;

ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; BIOLOGICAL ASSAY; BIOSENSING TECHNIQUES; CELL SEPARATION; DRUG EVALUATION, PRECLINICAL; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FLOW CYTOMETRY; MICROFLUIDIC ANALYTICAL TECHNIQUES; PHARMACEUTICAL PREPARATIONS; PROTEIN INTERACTION MAPPING; RECEPTORS, ADRENERGIC, BETA-2; STAINING AND LABELING; SYSTEMS INTEGRATION;

EID: 80053899050     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00033     Document Type: Article

References (32)

1. Strebhardt, K. & Ullrich, A. Paul Ehrlich's magic bullet concept: 100 years of progress. Nat. Rev. Cancer 8, 473-480 (2008). (Pubitemid 351752547)
2. Butcher, E. Can cell systems biology rescue drug discovery? Nat. Rev. Drug Discov. 4, 461-467 (2005). (Pubitemid 40861988)
3. Gleeson, M., Hersey, A., Montanari, D. & Overington, J. Probing the links between in vitro potency, ADMET and physicochemical parameters. Nat. Rev. Drug Discov. 10, 197-208 (2011).
4. Fliri, A. F., Loging, W. T., Thadeio, P. F. & Volkmann, R. A. Proc. Natl. Acad. Sci. USA 102, 261-266 (2005).
5. Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J. P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S. & Golub, T. R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 929-35 (2006).
6. Hoon, S., Smith, A. M., Wallace, I. M., Suresh, S., Miranda, M., Fung, E., Proctor, M., Shokat, K. M., Zhang, C., Davis, R. W., Giaever, G., St Onge, R. P. & Nislow, C. An integrated platform of genomic assays reveals small-molecule bioactivities. Nat. Chem. Biol. 4, 498-506 (2008).
7. Young, D. W., Bender, A., Hoyt, J., McWhinnie, E., Chirn, G.-W., Tao, C. Y., Tallarico, J. A., Labow, M., Jenkins, J. L., Mitchison, T. J. & Feng, Y. Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat. Chem. Biol. 4, 59-68 (2008). (Pubitemid 350273652)
8. Campillos, M., Kuhn, M., Gavin, A., Jensen, L. & Bork, P. Drug target identification using side-effect similarity. Science 321, 263-266 (2008). (Pubitemid 351989100)
9. Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., Whaley, R., Glennon, R. A., Hert, J., Thomas, K. L. H., Edwards, D. D., Shoichet, B. K. & Roth, B. L. Predicting new molecular targets for known drugs. Nature 462, 175-181 (2009).
10. Zhao, S. & Li, S. Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One 5, e11764 (2010).
11. Galandrin, S. & Bouvier, M. Distinct signaling profiles of b1 and b2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy. Mol. Pharmacol. 70, 1575-1584 (2006).
12. Kenakin, T. & Miller, L. J. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol. Rev. 62, 265-304 (2010).
13. Expert consensus document on b-adrenergic receptor blockers: The task force on beta-blockers of the European Society of Cardiology. Euro. Heart J. 25, 1341-1362 (2004).
14. Mehrotra, S., Gupta, S., Chan, K. Y., Villalon, C. M., Centurion, D., Saxena, P. R., Maassen, A. Current and prospective pharmacological targets in relation to antimigraine action. Naunyn-Schmiedeberg's Arch Pharmacol. 378, 371-394 (2008).
15. Hayreh, S. S., Podhajsky, P. & Zimmerman, M. B. Beta-blocker eyedrops and nocturnal arterial hypotension. Am. J. Ophthalmol. 128, 301-309 (1999). (Pubitemid 29413226)
16. Cruickshank, J. M. Beta-blockers continue to surprise us. Euro. Heart J. 21, 354-364 (2000). (Pubitemid 30107552)
17. Nguyen, L. P., Lin, R., Parra, S., Omoluabi, O., Hanania, N. A., Tuvim, M. J., Knoll, B. J., Dickey, B. F. & Bond, R. A. b2-Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc. Natl. Acad. Sci. USA 106, 2435-2440 (2009).
18. Lam, F. & Gill, P. Beta-agonist tocolytic therapy. Obstet. Gynecol. Clin. North Am. 32, 457-484 (2005).
19. Kenakin, T. Cellular assays as portals to seven-transmembrane receptor-based drug discovery. Nat. Rev. Drug Discov. 8, 617-626 (2009).
20. Fang, Y., Ferrie, A. M., Fontaine, N. H., Mauro, J. & Balakrishnan, J. Resonant waveguide grating biosensor for living cell sensing. Biophys. J. 91, 1925-1940 (2006). (Pubitemid 44352454)
21. Fang, Y., Ferrie, A. M., Fontaine, N. H. & Yuen, P. K. Characteristics of dynamic mass redistribution of epidermal growth factor receptor signaling in living cells measured with label-free optical biosensors. Anal. Chem. 77, 5720-5725 (2005). (Pubitemid 41266070)
22. Fang, Y. Label-free receptor assays. Drug Discov. Today Technol. 7, e5-e11 (2010).
23. Schröder, R., Janssen, N., Schmidt, K., Kebig, A., Merten, N., Hennen, S., Müller, A., Blättermann, S., Mohr-Andrä, M., Zahn, S., Wenzel, J., Smith, N. J., Gomeza, J., Drewke, C., Milligan, G., Mohr, K., Kostenis, E. Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements. Nat. Biotechnol. 28, 943-949 (2010).
24. Tran, T. M., Friedman, J., Qunaibi, E., Baameur, F., Moore, R. H. & Clark, R. B. Characterization of agonist stimulation of cAMP-dependent protein kinase andG protein-coupled receptor kinase phosphorylation of the b2-adrenergic receptor using phosphoserine-specific antibodies. Mol. Pharmacol. 65, 196-206 (2004). (Pubitemid 38113900)
25. Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868 (1998). (Pubitemid 29003722)
26. Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B. & Hassanali, M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucl. Acids Res. 36, D901-D906 (2007).
27. Bigal, M. E. & Krymchantowski, A. V. Emerging drugs for migraine prophylaxis and treatment. Med. Gen. Med. 8, 31 (2006).
28. Cao, Y., Charisi, A., Cheng, L. C., Jiang, T., Girke, T. ChemmineR: a compound mining framework for R. Bioinformatics 24, 1733-1734 (2008).
29. Fang, Y. & Ferrie, A. M. Label-free optical biosensor for ligand-directed functional selectivity acting on b2 adrenoceptor in living cells. FEBS Lett. 582, 558-564 (2008).
30. Goral, V., Jin, Y., Sun, H., Ferrie, A. M., Wu, Q. & Fang, Y. Agonist-directed desensitization of the b2-adrenergic receptor. PLoS One 6, e19282 (2011).
31. Rutten, F. H., Zuithoff, N., Hak, E., Grobbee, D. E. & Hoes, A. W. b-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch. Intern. Med. 170, 880-887 (2010).
32. Penn, R. B. Agonizing over agonism: should asthmatics turn their b-receptors on or off? Proc. Natl. Acad. Sci. USA 106, 2095-2096 (2009).